Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Bacterial Persistence as a Phenotypic Switch
2004 StandoutScience
Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon
2003
Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
2007 StandoutScience
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
2004
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
2003 StandoutScience
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
2014 StandoutNobel
B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis
2007
Type I IFN Induces IL-10 Production in an IL-27–Independent Manner and Blocks Responsiveness to IFN-γ for Production of IL-12 and Bacterial Killing in Mycobacterium tuberculosis –Infected Macrophages
2014
Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages
2011
TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production
2013
Hypervirulent M. tuberculosis W/Beijing Strains Upregulate Type I IFNs and Increase Expression of Negative Regulators of the Jak-Stat Pathway
2005
The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis
2007
Type I IFN Receptor Regulates Neutrophil Functions and Innate Immunity to Leishmania Parasites
2010
Fcγ Receptors Regulate Immune Activation and Susceptibility during Mycobacterium tuberculosis Infection
2008
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
2007
Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral Treatment
2010
Type I IFNs Enhance Susceptibility to Chlamydia muridarum Lung Infection by Enhancing Apoptosis of Local Macrophages
2008
HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic Mice
2003
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
PapA3 Is an Acyltransferase Required for Polyacyltrehalose Biosynthesis in Mycobacterium tuberculosis
2009 StandoutNobel
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
2014 Nature
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
2011
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
New concepts in the generation and functions of IgA
2012
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-α release
2006
Tuberculosis: a problem with persistence
2003
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
2007
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
2004 Nature
Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
2008
Dendritic Cells
2010
The role of IL-10 in immune regulation during M. tuberculosis infection
2011
Type I interferons in infectious disease
2015 Standout
NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis
2009
Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage Death
2008
Cancer immunotherapy via dendritic cells
2012 Standout
The clinical consequences of strain diversity in Mycobacterium tuberculosis
2008
Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice
2007
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
IFN-γ and NO in mycobacterial disease: new jobs for old hands
2002
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
2002
Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis
2011 StandoutNobel
Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β
2013
Fcγ receptors as regulators of immune responses
2007 Standout
Harnessing human dendritic cell subsets for medicine
2010
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Myd88 Is Required for an Antibody Response to Retroviral Infection
2009
Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection
2011
MyD88 and STING Signaling Pathways Are Required for IRF3-Mediated IFN-β Induction in Response to Brucella abortus Infection
2011
Some interfaces of dendritic cell biology
2003 StandoutNobel
Does M. tuberculosis genomic diversity explain disease diversity?
2010
Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development
2007
NOD1 and NOD2 signalling links ER stress with inflammation
2016 StandoutNature
Virulence of SelectedMycobacterium tuberculosisClinical Isolates in the Rabbit Model of Meningitis Is Dependent on Phenolic Glycolipid Produced by the Bacilli
2005
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The who, how and where of antigen presentation to B cells
2008
Immunity, Inflammation, and Cancer
2010 Standout
Dendritic cell subsets in health and disease
2007
The Mycobacterium tuberculosis PhoPR two‐component system regulates genes essential for virulence and complex lipid biosynthesis
2006
The immunological aspects of latency in tuberculosis
2003
Cancer immunotherapy comes of age
2011 StandoutNature
How B cells shape the immune response against Mycobacterium tuberculosis
2009
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
2010
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
2012
Cancer Immunotherapy by Dendritic Cells
2008
Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway
2013
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Type I Interferon Induction Is Detrimental during Infection with the Whipple's Disease Bacterium, Tropheryma whipplei
2010
Tumour necrosis factor and cancer
2009
Eliminating latent tuberculosis
2009
The Role of MmpL8 in Sulfatide Biogenesis and Virulence of Mycobacterium tuberculosis
2004
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo
2007
Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
2010
FcRn: the neonatal Fc receptor comes of age
2007 Standout
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
2010
Role of innate cytokines in mycobacterial infection
2011
B Cells Acquire Particulate Antigen in a Macrophage-Rich Area at the Boundary between the Follicle and the Subcapsular Sinus of the Lymph Node
2007
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
2011
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
2010
Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells
2006 Science
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
A Critical Role for Syk Protein Tyrosine Kinase in Fc Receptor-Mediated Antigen Presentation and Induction of Dendritic Cell Maturation
2003
Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma
2003
Protection against Progressive Leishmaniasis by IFN-β
2004
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Tuberculosis Pathogenesis and Immunity
2011
Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes
2002
Expression of an anti‐RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN ‐I expression
2013
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
2012
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Mycobacterium tuberculosisDiverts Alpha Interferon-Induced Monocyte Differentiation from Dendritic Cells into Immunoprivileged Macrophage-Like Host Cells
2004
Evolutionary Causes and Consequences of Immunopathology
2005
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
IFN-γ enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation
2004
Mucosal Dendritic Cells
2007
A sulfated metabolite produced bystf3negatively regulates the virulence ofMycobacteriumtuberculosis
2006 StandoutNobel
Improved Tumor Immunity Using Anti-Tyrosinase Related Protein-1 Monoclonal Antibody Combined with DNA Vaccines in Murine Melanoma
2008
Disease Tolerance as a Defense Strategy
2012 StandoutScience
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
2003 StandoutNobel
Type I interferon: friend or foe?
2010
The Immune Response in Tuberculosis
2013 Standout
Innate Immune Recognition ofMycobacterium tuberculosis
2011
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Deletion of Two-Component Regulatory Systems Increases the Virulence of Mycobacterium tuberculosis
2003
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy
2007
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
2003
The Phenolic Glycolipid ofMycobacterium tuberculosisDifferentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence
2008
The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation
2007
STAT1 Regulates IFN-αβ- and IFN-γ-Dependent Control of Infection withChlamydia pneumoniaeby Nonhemopoietic Cells
2006
Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate ofMycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology
2000
Tolerogenic Dendritic Cells
2003 StandoutNobel
Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling
2007 StandoutNobel
PapA1 and PapA2 are acyltransferases essential for the biosynthesis of theMycobacterium tuberculosisvirulence factor Sulfolipid-1
2007 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
2011
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Defining dendritic cells by conditional and constitutive cell ablation
2010
Contribution of theMycobacterium tuberculosisMmpL Protein Family to Virulence and Drug Resistance
2005
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles
2007
Reactivation of Latent Tuberculosis Infection in TNF-Deficient Mice
2003
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Type I Interferons Increase Host Susceptibility to Trypanosoma cruzi Infection
2011
Works of Amy Bergtold being referenced
Virulence of aMycobacterium tuberculosisclinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
2001
Aerosol infection of mice with recombinant BCG secreting murine IFN-γ partially reconstitutes local protective immunity
2000
Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells
2005
Redundant and Alternative Roles for Activating Fc Receptors and Complement in an Antibody-Dependent Model of Autoimmune Vitiligo
2002
Mycobacterium tuberculosis CDC1551 Induces a More Vigorous Host Response In Vivo and In Vitro, But Is Not More Virulent Than Other Clinical Isolates
1999
Immune complex–mediated antigen presentation induces tumor immunity
2002
Immune complex–mediated antigen presentation induces tumor immunity
2002
Immunopathologic Effects of Tumor Necrosis Factor Alpha in Murine Mycobacterial Infection Are Dose Dependent
2000
Fcγ Receptor IIB on Dendritic Cells Enforces Peripheral Tolerance by Inhibiting Effector T Cell Responses
2007
Immune complex–mediated antigen presentation induces tumor immunity
2002
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
2006
Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system
1999